Worth Venture Partners, LLC Entera Bio Ltd. Transaction History

Worth Venture Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$1.84 - $2.97 $30,275 - $48,868	-16,454 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$2.11 - $3.75 $932 - $1,657	442 Added 2.76%	16,454 $39,000
Q2 2019 Aug 14, 2019	BUY	$2.92 - $4.4 $3,103 - $4,677	1,063 Added 7.11%	16,012 $49,000
Q1 2019 May 15, 2019	SELL	$3.01 - $4.84 $36,113 - $58,070	-11,998 Reduced 44.52%	14,949 $65,000
Q4 2018 Feb 15, 2019	BUY	$3.0 - $5.85 $43,017 - $83,883	14,339 Added 113.73%	26,947 $53,000
Q3 2018 Nov 15, 2018	BUY	$4.5 - $6.7 $56,736 - $84,473	12,608 New	12,608 $73,000

5.34M

2.6K

100

Ticker ENTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,809,900
Market Cap $60.2M
Description
Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed ...

Get notified when there are updates to the investment portfolio of Worth Venture Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Worth Venture Partners, LLC with notifications on news.